GSK expands restructuring, reports earnings

GlaxoSmithKline (LSE:GSK; NYSE:GSK) said in its 4Q08 earnings that it will expand the restructuring program that the company began in 2007. GSK said it will

Read the full 257 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE